Regenerated organs, space medicine and barrier-free healthcare
The biomedical sector, as emerged once again in Verona at “Innovabiomed”, is approaching goals that were unimaginable just a few years ago
In the biomedical field, hi-tech solutions and nanotechnologies are emerging and are ready to take on a leading role in personal care; space missions represent an excellent ground for unprecedented experiments in the biomedical field, from material science to 3D printing.
In addition, decellularization techniques are advancing, useful for example to transplant organs even in the absence of a donor. Projects and innovations that require strategic investments and funding to translate discoveries into technological solutions, and a great teamwork.
Walter Ricciardi in Verona: “A pandemic treaty is needed…”
Innovation and the healthcare sector meet in Verona
The focus is on improving people’s quality of life
This was also the theme of the inaugural conference of “Innovabiomed”, the network place for biomedical innovation which, until tomorrow, involves researchers, device manufacturers, doctors and professionals at Veronafiere to connect different skills and disciplines, useful for the development of a sector in which technological progress makes a decisive contribution to improving people’s quality of life.
Giampaolo Tortora: “Too Many Late Oncology Diagnoses…”
Repopulating the heart scaffold with the patient’s own cells
According to Gino Gerosa, Professor of Cardiac Surgery at the Faculty of Medicine of the University of Padua, Director of the Cardiac Surgery Center and of the Heart Transplantation and Mechanical Assistance Program of the Azienda Ospedaliera-University of Padua, Past President of the Italian Society of Cardiac Surgery and member of the Scientific Committee of Innovabiomed, “Thanks to research and multidisciplinary skills we are approaching goals that were unimaginable just a few years ago. A sector in great evolution is related to the replacement therapy of organs and tissues; the development of regenerative medicine and tissue engineering is opening scenarios of absolute importance. Decellularization, for example, allows us to eliminate the entire cellular component that characterizes the tissue of an organ. By removing this component we are able to obtain the architecture, the extra-cellular matrix. Thanks to this process we have the possibility to repopulate the scaffold of the heart with the patient’s own cells, because what we want to implement is a translational but also personalized medicine, which starts from the patient’s own cells that we can recover through non-invasive techniques. With the Lifelab project of the Veneto Region we have given ourselves five years of time to get to implant such a heart on a patient, with greater biocompatibility than transplantation from a donor. The goal of this area of research is to develop useful tools for the treatment of end-stage diseases, regenerating entire organs and reconstructing tissues, such as ears, trachea, larynx, esophagus, skeletal muscles, urinary ducts, nerves and others”.
At “Innovabiomed” the heart valve that will change healthcare
Video, the presentation of “Innovabiomed” 2021 in Verona
Breaking down the public-private barrier is essential
Mauro Ferrari, CEO BrYet Pharma and Professor of Pharmaceutical Sciences at the University of Washington, says: “We have to go against the barriers: it is very clear that creating divisions in the medical field is absolutely harmful, breaking down these divisions allows us to find new solutions to global health problems, such as pandemics, but also local ones. We want to break down the divisions between scientific disciplines and between regional communities, it is not possible to face an emergency one nation at a time, we need a global convergence, the last barrier that must be overcome is that between public and private, an overcoming that is fundamental and I think that ‘Innovabiomed’ and what it represents goes exactly in this direction”.
“Innovabiomed”: 20 happening, 100 relatori, tanto networking
Alberto Nicolini: “The city of Pico is always up to the task”
Giant strides thanks to health coming from… space
Tommaso Ghidini, Head of the Structures, Mechanisms and Materials Division of ESA, the European Space Agency, also adds: “The link between the European Space Agency and the world of health concerns two aspects: there is health for space, which is the one that safeguards astronauts and health from space, to protect life on Earth, about the latter I wanted to talk at ‘Innovabiomed’. We have made incredible developments on telemedicine thanks to the international space station, of remote diagnosis, of data transmission, we have also worked on converted field hospitals that were born for the Ebola virus and have been put in the field for the COVID19 emergency”.
“Innovabiomed” is an event organized by Veronafiere in collaboration with distrettobiomedicale.it; it is sponsored by Regione Veneto, Provincia di Verona, Comune di Verona, Università di Verona, Università di Padova, Ordine Nazionale dei Biologi, Federazione Regionale degli Ordini dei Medici Chirururghi e degli Odontoiatri del Veneto. Organizing partner is RPM Media. Sponsors: CPL Concordia, Euroimmun, Overtech.
In Verona on July 2-3 there is the biomedical of “Innovabiomed”
“Mirandola’s biomedical? World excellence of Europe”
